Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Neoplasm Metastasis 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Genetic Diseases, Inborn 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphangioma × Alpelisib × 30 days × Clear all

NCT05948943 2026-06-02

EPIK-L1

Novartis

Phase 2/3 Recruiting

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡